Trials / Completed
CompletedNCT04714242
OCTA and Polypoidal Choroidal Vasculopathy
Choroid and Choriocapillary Changes in Polypoidal Choroidal Vasculopathy After Intravitreal Anti-VEGF Therapy
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 60 (actual)
- Sponsor
- Federico II University · Academic / Other
- Sex
- All
- Age
- 60 Years – 80 Years
- Healthy volunteers
- —
Summary
To investigate the structural and vascular features of choroid in patients affected by PCV after Ranibizumab intravitreal injection.
Detailed description
Polypoidal choroidal vasculopathy represents a distinct form of choroidal neovascularization. The study investigated the changes in choroidal vascular network after anti-VEGF therapy using optical coherence tomography angiography, a novel and non invasive diagnostic technique that allows to better understand the pathophysiologic mechanism of this neovascularization.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ranibizumab Injection | Three monthly intravitreal injections of Ranibizumab |
Timeline
- Start date
- 2019-01-15
- Primary completion
- 2020-12-15
- Completion
- 2020-12-20
- First posted
- 2021-01-19
- Last updated
- 2021-01-19
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT04714242. Inclusion in this directory is not an endorsement.